Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease

Explore clinical trials studying Chronic Obstructive Pulmonary Disease. Study availability and eligibility vary by location and protocol.

1,238 public trials 82 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease trial results

Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Chandler Clinical Research Trials- Site Number : 8400025 Chandler, Arizona, United States
  • Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114 Phoenix, Arizona, United States
  • Epic Medical Research - Surprise- Site Number : 8400096 Surprise, Arizona, United States
  • IMAX Clinical Trials- Site Number : 8400109 La Palma, California, United States
View all 294 locations
View Trial Details
Recruiting

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

NCT07053423

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • University of Alabama at Birmingham - School of Medicine- Site Number : 8400003 Birmingham, Alabama, United States
  • Finlay Medical Research- Site Number : 8400010 Miami, Florida, United States
  • Private Practice - Dr. David Kavtaradze- Site Number : 8400017 Cordele, Georgia, United States
  • University of Kansas Medical Center- Site Number : 8400005 Kansas City, Kansas, United States
View all 82 locations
View Trial Details
Recruiting

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT07793409

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Newport Native MD- Site Number : 8403003 Newport Beach, California, United States
  • Helix Biomedics- Site Number : 8403065 Boynton Beach, Florida, United States
  • Investigational Site Number : 8264017 Rotherham, United Kingdom
View Trial Details
Recruiting

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT07073950

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +7 more
Locations
  • Research Site Ahrensburg, Germany
  • Research Site Berlin, Germany
  • Research Site Frankfurt, Germany
  • Research Site Hanover, Germany
View Trial Details
Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

NCT07190222

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • University of Alabama at Birmingham- Site Number : 8400003 Birmingham, Alabama, United States
  • Tucson Clinical Research Institute- Site Number : 8400006 Tucson, Arizona, United States
  • Inglewood Clinical- Site Number : 8400074 Inglewood, California, United States
  • Ark Clinical Research- Site Number : 8400113 Long Beach, California, United States
View all 214 locations
View Trial Details
Recruiting

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

NCT06603246

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Accel Research Site - Achieve - Birmingham - ERN - PPDS Vestavia Hills, Alabama, United States
  • Stanford Center for Excellence in Pulmonary Biology Palo Alto, California, United States
  • University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd Kansas City, Kansas, United States
View Trial Details

Related conditions